SHPH Shuttle Pharmaceuticals Holdings, Inc.
Healthcare$0.59+0.64%ClosedMarket Cap: $627,473
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.88
P/S
0.00
EV/EBITDA
0.02
DCF Value
$-0.71
FCF Yield
-1493.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-408.3%
ROA
-91.6%
ROIC
-312.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-2.2M | $-2.2M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.8M | $-2.6M | $— | — |
| FY null | $0.00 | NaN% | $-11.9M | $-11.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.3M | $-2.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.9M | $-3.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.0M | $-3.1M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-1.8M | $-1.6M | $— | — |
| FY null | $0.00 | NaN% | $-7.7M | $-9.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.1M | $-3.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.5M | $-2.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.4M | $-1.7M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-1.3M | $-1.6M | $-0.10 | — |